Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIS410 in Healthy Subjects Inoculated with Influenza A (H1N1)
NCT02468115Phase 2Completed
- Sponsor
- Visterra
- Start
- May 2015
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of VIS410 in Influenza A (IAV), sponsored by Visterra. Started May 2015; status: completed.
02
Drugs
VIS410
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02468115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468115.